These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 24051434)
1. Tolerability of intramuscular and intradermal delivery by CELLECTRA(®) adaptive constant current electroporation device in healthy volunteers. Diehl MC; Lee JC; Daniels SE; Tebas P; Khan AS; Giffear M; Sardesai NY; Bagarazzi ML Hum Vaccin Immunother; 2013 Oct; 9(10):2246-52. PubMed ID: 24051434 [TBL] [Abstract][Full Text] [Related]
2. A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation. Hannaman D; Dupuy LC; Ellefsen B; Schmaljohn CS Vaccine; 2016 Jun; 34(31):3607-12. PubMed ID: 27206386 [TBL] [Abstract][Full Text] [Related]
3. Enhanced immunogenicity and protective efficacy of a tetravalent dengue DNA vaccine using electroporation and intradermal delivery. Williams M; Ewing D; Blevins M; Sun P; Sundaram AK; Raviprakash KS; Porter KR; Sanders JW Vaccine; 2019 Jul; 37(32):4444-4453. PubMed ID: 31279565 [TBL] [Abstract][Full Text] [Related]
4. Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers. Tebas P; Kraynyak KA; Patel A; Maslow JN; Morrow MP; Sylvester AJ; Knoblock D; Gillespie E; Amante D; Racine T; McMullan T; Jeong M; Roberts CC; Park YK; Boyer J; Broderick KE; Kobinger GP; Bagarazzi M; Weiner DB; Sardesai NY; White SM J Infect Dis; 2019 Jul; 220(3):400-410. PubMed ID: 30891607 [TBL] [Abstract][Full Text] [Related]
5. HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial. Nilsson C; Hejdeman B; Godoy-Ramirez K; Tecleab T; Scarlatti G; Bråve A; Earl PL; Stout RR; Robb ML; Shattock RJ; Biberfeld G; Sandström E; Wahren B PLoS One; 2015; 10(6):e0131748. PubMed ID: 26121679 [TBL] [Abstract][Full Text] [Related]
6. Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP Edupuganti S; C De Rosa S; Elizaga M; Lu Y; Han X; Huang Y; Swann E; Polakowski L; A Kalams S; Keefer M; Maenza J; C Wise M; Yan J; Morrow MP; Khan AS; Boyer JD; Humeau L; White S; Sardesai NY; Bagarazzi ML; Gilbert PB; Kublin JG; Corey L; Weiner DB; On Behalf Of The Hvtn Study Team ; The Niaid-Funded Hiv Vaccine Trials Network Vaccines (Basel); 2020 Dec; 8(4):. PubMed ID: 33297341 [TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318 [TBL] [Abstract][Full Text] [Related]
8. A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle. Lin F; Shen X; McCoy JR; Mendoza JM; Yan J; Kemmerrer SV; Khan AS; Weiner DB; Broderick KE; Sardesai NY Vaccine; 2011 Sep; 29(39):6771-80. PubMed ID: 21199706 [TBL] [Abstract][Full Text] [Related]
9. Integration of needle-free jet injection with advanced electroporation delivery enhances the magnitude, kinetics, and persistence of engineered DNA vaccine induced immune responses. Jiang J; Ramos SJ; Bangalore P; Fisher P; Germar K; Lee BK; Williamson D; Kemme A; Schade E; McCoy J; Muthumani K; Weiner DB; Humeau LM; Broderick KE Vaccine; 2019 Jun; 37(29):3832-3839. PubMed ID: 31174938 [TBL] [Abstract][Full Text] [Related]
10. Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaques. Kulkarni V; Rosati M; Bear J; Pilkington GR; Jalah R; Bergamaschi C; Singh AK; Alicea C; Chowdhury B; Zhang GM; Kim EY; Wolinsky SM; Huang W; Guan Y; LaBranche C; Montefiori DC; Broderick KE; Sardesai NY; Valentin A; Felber BK; Pavlakis GN Hum Vaccin Immunother; 2013 Oct; 9(10):2081-94. PubMed ID: 23811579 [TBL] [Abstract][Full Text] [Related]
11. In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers. Vasan S; Hurley A; Schlesinger SJ; Hannaman D; Gardiner DF; Dugin DP; Boente-Carrera M; Vittorino R; Caskey M; Andersen J; Huang Y; Cox JH; Tarragona-Fiol T; Gill DK; Cheeseman H; Clark L; Dally L; Smith C; Schmidt C; Park HH; Kopycinski JT; Gilmour J; Fast P; Bernard R; Ho DD PLoS One; 2011; 6(5):e19252. PubMed ID: 21603651 [TBL] [Abstract][Full Text] [Related]
12. Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device. Lin F; Shen X; Kichaev G; Mendoza JM; Yang M; Armendi P; Yan J; Kobinger GP; Bello A; Khan AS; Broderick KE; Sardesai NY Hum Gene Ther Methods; 2012 Jun; 23(3):157-68. PubMed ID: 22794496 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and safety of intradermal delivery of hepatitis B booster vaccine using the novel drug delivery device VAX-ID™. Van Mulder TJS; Withanage K; Beyers KCL; Vankerckhoven VVJ; Theeten H; Van Damme P Vaccine; 2019 Jan; 37(4):581-586. PubMed ID: 30587432 [TBL] [Abstract][Full Text] [Related]
14. Electroporation of a nanoparticle-associated DNA vaccine induces higher inflammation and immunity compared to its delivery with microneedle patches in pigs. Bernelin-Cottet C; Urien C; McCaffrey J; Collins D; Donadei A; McDaid D; Jakob V; Barnier-Quer C; Collin N; Bouguyon E; Bordet E; Barc C; Boulesteix O; Leplat JJ; Blanc F; Contreras V; Bertho N; Moore AC; Schwartz-Cornil I J Control Release; 2019 Aug; 308():14-28. PubMed ID: 31265882 [TBL] [Abstract][Full Text] [Related]